Provided by Tiger Trade Technology Pte. Ltd.

Global Partners LP

50.38
-0.1900-0.38%
Post-market: 50.380.00000.00%19:30 EDT
Volume:56.14K
Turnover:2.82M
Market Cap:1.71B
PE:10.31
High:50.75
Open:50.75
Low:49.88
Close:50.57
52wk High:53.25
52wk Low:39.58
Shares:34.00M
Float Shares:27.67M
Volume Ratio:0.75
T/O Rate:0.20%
Dividend:3.06
Dividend Rate:6.06%
EPS(TTM):4.89
EPS(LYR):2.11
ROE:27.21%
ROA:5.25%
PB:2.55
PE(LYR):23.88

Loading ...

Earning Preview: Global Partners LP this quarter’s revenue is expected to increase by 23.69%, and institutional views are mixed

Earnings Agent
·
May 01

Press Release: Global Partners Declares First-Quarter 2026 Cash Distribution of $0.7650 on Common Units

Dow Jones
·
Apr 30

Loblaw Earns Buy Rating on Strong Earnings Momentum, Market Share Gains and GLP‑1 Growth Tailwinds

TIPRANKS
·
Apr 30

Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease

GlobeNewswire
·
Apr 28

A Look At Insulet (PODD) Valuation After Device Correction And Growing GLP-1 Competition Concerns

Simply Wall St.
·
Apr 28

ASCLETIS-B Completes Patient Enrollment for US Phase II Trial of Oral GLP-1R Agonist ASC30 in Diabetes

Stock News
·
Apr 27

Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes

prnewswire
·
Apr 27

Wedding Dresses Now Come With a Legal Waiver for Brides on GLP-1s -- WSJ

Dow Jones
·
Apr 25

Is It Time To Reassess Global Partners (GLP) After Recent Energy Sector Coverage?

Simply Wall St.
·
Apr 25

Global Partners schedules first-quarter results conference call

Reuters
·
Apr 24

Domestic Long-Acting GLP-1 Drug Tops 100 Million Yuan in First-Year Sales but Faces Deepening Losses

Deep News
·
Apr 24

โมเดลการดูแลแบบผสมผสานของ NOVI Health ช่วยปิดช่องว่างระหว่างผลลัพธ์การทดลองทางคลินิกกับผลลัพธ์การใช้จริงของยา GLP-1

prnewswire
·
Apr 22

NOVI Health's Hybrid Care Model Closes Gap Between Clinical Trials and Real-World GLP-1 Outcomes

prnewswire
·
Apr 22

QHSLab Reports Strong Q1 Growth and Launches GLP-1 Program

TIPRANKS
·
Apr 21

GLP-1 boom nudges U.S. cannabis dispensaries to rethink offerings

Bloomberg
·
Apr 21

LifeMD Shares Rise After Offering Lilly's GLP-1 Obesity Pill

Dow Jones
·
Apr 21

ResMed: Buy Rating on Depressed Valuation as Market Overprices Philips and GLP‑1 Risks

TIPRANKS
·
Apr 17

ASCLETIS-B Shares Surge Nearly 5% in Afternoon Trading, Approaching All-Time High as GLP-1 and Amylin Combo Enters Clinical Trials

Stock News
·
Apr 17

TYK MEDICINES-B's (02410) Self-Developed TY-3002 Monotherapy Demonstrates Outstanding Weight Loss Efficacy, Pioneering Next-Generation Oral GLP-1R Small Molecule Innovation

Stock News
·
Apr 16

Lexaria Launches New GLP-1 Study to Expand Drug Delivery IP

TIPRANKS
·
Apr 15